
OLD Category: pan cancer panels
February 6, 2019 / Gastroenterology
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
February 4, 2019 / Nat Commun.
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
February 2, 2019 / Gut
RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours
February 1, 2019 / Clin Cancer Res
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
January 30, 2019 / Sci Transl Med.
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
January 29, 2019 / Front Immunol.
CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
January 21, 2019 / Nat Nanotechnol
Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
January 18, 2019 / Cancer Immunol Res.
Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
January 10, 2019 / JCI Insight
Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma
January 8, 2019 / Nat Commun.